Total Debt
$1.4M
Net Debt
-$538.3M
Bicara Therapeutics Inc. Common Stock currently has $1.4M in total debt. Net debt is -$538.3M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
BCAX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.54 | -0.54Net Cash | 0.55 | 0.3% |
| 2025-12-31 | 0.00 | 0.41 | -0.41Net Cash | 0.43 | 0.4% |
| 2025-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.42 | 0.5% |
| 2025-06-30 | 0.00 | 0.44 | -0.43Net Cash | 0.45 | 0.5% |
| 2025-03-31 | 0.00 | 0.46 | -0.46Net Cash | 0.48 | 0.1% |
| 2024-12-31 | 0.00 | 0.49 | -0.49Net Cash | 0.57 | 0.1% |
| 2024-09-30 | 0.00 | 0.52 | -0.52Net Cash | 0.52 | 0.1% |
| 2024-06-30 | 0.00 | 0.20 | -0.20Net Cash | 0.21 | 0.2% |
| 2024-03-31 | 0.00 | 0.20 | -0.20Net Cash | 0.21 | 0.2% |
| 2023-12-31 | 0.00 | 0.23 | -0.23Net Cash | 0.23 | 0.3% |
| 2023-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |